EUVIMEDEUVIMED entdecken
Open Access

Recovery From Heart Failure: Microvascular Mechanisms

Shuang Li iD, Krishan Gupta iD, Rajul K Ranka iD, Alexander J Lu iD, Felix Naegele, Michael Graber iD, Kaylee N Carter iD, Lili Zhang iD, Arvind Bhimaraj iD, Li Lai iD, Anahita Mojiri iD, Keith A Youker iD und 2 weitere

Circulation · 26.05.2026 · 153 (21) · 1661-1678

DOI: 10.1161/circulationaha.125.078996 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 26.05.2026. Verfasst von Shuang Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cardiovascular Regeneration, Houston Methodist Research Institute, Houston, TX (S.L., R.K.R., A.J.L., F.N., M.G., K.N.C., L.L., A.M., K.A.…. Hauptthemen laut MEDLINE: Heart Failure, Heart-Assist Devices, Microvessels. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Heart failure (HF) is a significant global health problem. Left ventricular assist device (LVAD) implantation serves as a bridge for patients awaiting heart transplantation. Intriguingly, LVAD support often improves cardiac histology and function, sometimes enough to avoid transplantation after LVAD removal. However, the cellular programs underlying this recovery remain unclear. METHODS: Myocardial tissues were obtained from patients with HF at the time of LVAD implantation (pre LVAD) and explantation (post LVAD) for histological analysis and single-nucleus RNA sequencing. A murine model of HF recovery, combined with lineage tracing studies, was employed to define cellular sources of vascular repair. Cardiac function, fibrosis, and vascular density were assessed using echocardiography, histology, and fluorescent microsphere perfusion. A patient-derived cardiac nonmyocyte culture system was established to interrogate mechanisms of cell fate regulation. RESULTS: Post-LVAD myocardial tissues exhibited reduced fibrosis and increased capillary density compared with pre-LVAD samples. Across samples, fibroblast abundance was inversely correlated with endothelial cell abundance, consistent with enhanced angiogenesis during recovery. Single-nucleus RNA sequencing identified a fibroblast subset predisposed to undergo mesenchymal-to-endothelial transition, acquiring an endothelial cell identity. Additionally, nonmyocytes from pre-LVAD hearts proliferated poorly and failed to form vascular structures, whereas nonmyocytes from post-LVAD hearts displayed greater proliferation and angiogenesis capacity, forming vessel-like structures, reinforcing the association of HF recovery with angiogenic reprogramming. Mechanistically, knockdown of c-Myc (cellular myelocytomatosis oncogene) by small interfering RNA shifted post-LVAD nonmyocytes to a pre-LVAD–like state, while c-Myc overexpression by mRNA in pre-LVAD cells induced a post-LVAD–like phenotype, implicating c-Myc as 1 contributor to this fate switch. A model of HF recovery in mice mimicked the histological and functional changes in patients, with physiological evidence of increased microvascular perfusion, associated with a fibroblast-to-endothelial transition, documented by lineage tracing. CONCLUSIONS: HF recovery involves reduced fibrosis and enhanced microvascularization, partly driven by fibroblast-to-endothelial cell fate transition. c-Myc functions as 1 regulator of this transition, offering a mechanistic entry point to develop regenerative therapies in HF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureHeart-Assist DevicesMicrovesselsAnimalsHumansMiceProto-Oncogene Proteins c-mycFibrosisFibroblastsFemaleRecovery of FunctionMaleMyocardiumEndothelial CellsMice, Inbred C57BLEndothelial-Mesenchymal TransitionNeovascularization, PhysiologicDisease Models, AnimalCells, Cultured

Stichwörter der Autor:innen

heart failureleft ventricular assist devicesingle-nucleus sequencingtransdifferentiationvascular

Substanzen

Proto-Oncogene Proteins c-mycMYC protein, human

Autor:innen und Institutionen

  • Center for Cardiovascular Regeneration, Houston Methodist Research Institute, Houston, TX (S.L., R.K.R., A.J.L., F.N., M.G., K.N.C., L.L., A.M., K.A.Y., J.P.C.).
  • Department of Cardiology, Boston Children's Hospital, Boston, MA (K.G., L.Z., K.C.).
  • Department of Pediatrics, Harvard Medical School, Boston, MA (K.G., L.Z., K.C.).
  • Department of Cardiology, Houston Methodist Hospital, Houston, TX (A.B.).

ORCID-Profile: Shuang Li, Krishan Gupta, Rajul K Ranka, Alexander J Lu, Michael Graber, Kaylee N Carter, Lili Zhang, Arvind Bhimaraj, Li Lai, Anahita Mojiri, Keith A Youker, Kaifu Chen, John P Cooke

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Li, S., Gupta, K., Ranka, R. K., Lu, A. J., Naegele, F., Graber, M., Carter, K. N., Zhang, L., Bhimaraj, A., Lai, L., Mojiri, A., Youker, K. A., Chen, K., & Cooke, J. P. (2026). Recovery From Heart Failure: Microvascular Mechanisms. Circulation, 153(21), 1661-1678. https://doi.org/10.1161/circulationaha.125.078996

Vancouver

Li S, Gupta K, Ranka RK, Lu AJ, Naegele F, Graber M, et al. Recovery From Heart Failure: Microvascular Mechanisms. Circulation. 2026;153(21):1661-1678. doi:10.1161/circulationaha.125.078996

BibTeX
@article{Li2026,
  author = {Li, Shuang and Gupta, Krishan and Ranka, Rajul K and Lu, Alexander J and Naegele, Felix and Graber, Michael and Carter, Kaylee N and Zhang, Lili and Bhimaraj, Arvind and Lai, Li and Mojiri, Anahita and Youker, Keith A and Chen, Kaifu and Cooke, John P},
  title = {Recovery From Heart Failure: Microvascular Mechanisms},
  journal = {Circulation},
  year = {2026},
  volume = {153},
  number = {21},
  pages = {1661--1678},
  doi = {10.1161/circulationaha.125.078996}
}
Kostenlos starten →